UBXN11 and hepatocellular carcinoma: We have previously observed SOC entry to increase following TRPC1 silencing, suggesting a negative regulatory role of TRPC1 in SOC entry both in vascular smooth muscle and hepatocellular carcinoma cells [15, 16].